Cargando…
Pricing New Drugs for COVID-19 in the Pharmaceutical Industry: Insights From the Chinese Medical Insurance
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Kerman University of Medical Sciences
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461880/ https://www.ncbi.nlm.nih.gov/pubmed/37579370 http://dx.doi.org/10.34172/ijhpm.2023.7972 |
| _version_ | 1785097929421225984 |
|---|---|
| author | Lu, Jinmiao Ying, Xiaohua Li, Zhiping |
| author_facet | Lu, Jinmiao Ying, Xiaohua Li, Zhiping |
| author_sort | Lu, Jinmiao |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10461880 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Kerman University of Medical Sciences |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104618802023-08-29 Pricing New Drugs for COVID-19 in the Pharmaceutical Industry: Insights From the Chinese Medical Insurance Lu, Jinmiao Ying, Xiaohua Li, Zhiping Int J Health Policy Manag Letter to Editor Kerman University of Medical Sciences 2023-06-18 /pmc/articles/PMC10461880/ /pubmed/37579370 http://dx.doi.org/10.34172/ijhpm.2023.7972 Text en © 2023 The Author(s); Published by Kerman University of Medical Sciences https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to Editor Lu, Jinmiao Ying, Xiaohua Li, Zhiping Pricing New Drugs for COVID-19 in the Pharmaceutical Industry: Insights From the Chinese Medical Insurance |
| title | Pricing New Drugs for COVID-19 in the Pharmaceutical Industry: Insights From the Chinese Medical Insurance |
| title_full | Pricing New Drugs for COVID-19 in the Pharmaceutical Industry: Insights From the Chinese Medical Insurance |
| title_fullStr | Pricing New Drugs for COVID-19 in the Pharmaceutical Industry: Insights From the Chinese Medical Insurance |
| title_full_unstemmed | Pricing New Drugs for COVID-19 in the Pharmaceutical Industry: Insights From the Chinese Medical Insurance |
| title_short | Pricing New Drugs for COVID-19 in the Pharmaceutical Industry: Insights From the Chinese Medical Insurance |
| title_sort | pricing new drugs for covid-19 in the pharmaceutical industry: insights from the chinese medical insurance |
| topic | Letter to Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461880/ https://www.ncbi.nlm.nih.gov/pubmed/37579370 http://dx.doi.org/10.34172/ijhpm.2023.7972 |
| work_keys_str_mv | AT lujinmiao pricingnewdrugsforcovid19inthepharmaceuticalindustryinsightsfromthechinesemedicalinsurance AT yingxiaohua pricingnewdrugsforcovid19inthepharmaceuticalindustryinsightsfromthechinesemedicalinsurance AT lizhiping pricingnewdrugsforcovid19inthepharmaceuticalindustryinsightsfromthechinesemedicalinsurance |